280 related articles for article (PubMed ID: 29953201)
1. Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine.
Perni M; Flagmeier P; Limbocker R; Cascella R; Aprile FA; Galvagnion C; Heller GT; Meisl G; Chen SW; Kumita JR; Challa PK; Kirkegaard JB; Cohen SIA; Mannini B; Barbut D; Nollen EAA; Cecchi C; Cremades N; Knowles TPJ; Chiti F; Zasloff M; Vendruscolo M; Dobson CM
ACS Chem Biol; 2018 Aug; 13(8):2308-2319. PubMed ID: 29953201
[TBL] [Abstract][Full Text] [Related]
2. A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity.
Perni M; Galvagnion C; Maltsev A; Meisl G; Müller MB; Challa PK; Kirkegaard JB; Flagmeier P; Cohen SI; Cascella R; Chen SW; Limbocker R; Sormanni P; Heller GT; Aprile FA; Cremades N; Cecchi C; Chiti F; Nollen EA; Knowles TP; Vendruscolo M; Bax A; Zasloff M; Dobson CM
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E1009-E1017. PubMed ID: 28096355
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of α-synuclein aggregation within liquid condensates.
Dada ST; Toprakcioglu Z; Cali MP; Röntgen A; Hardenberg MC; Morris OM; Mrugalla LK; Knowles TPJ; Vendruscolo M
Nat Commun; 2024 May; 15(1):3835. PubMed ID: 38714700
[TBL] [Abstract][Full Text] [Related]
4. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
[TBL] [Abstract][Full Text] [Related]
5. Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease.
Hideshima M; Kimura Y; Aguirre C; Kakuda K; Takeuchi T; Choong CJ; Doi J; Nabekura K; Yamaguchi K; Nakajima K; Baba K; Nagano S; Goto Y; Nagai Y; Mochizuki H; Ikenaka K
Sci Rep; 2022 Jan; 12(1):351. PubMed ID: 35013421
[TBL] [Abstract][Full Text] [Related]
6. Trodusquemine enhances Aβ
Limbocker R; Chia S; Ruggeri FS; Perni M; Cascella R; Heller GT; Meisl G; Mannini B; Habchi J; Michaels TCT; Challa PK; Ahn M; Casford ST; Fernando N; Xu CK; Kloss ND; Cohen SIA; Kumita JR; Cecchi C; Zasloff M; Linse S; Knowles TPJ; Chiti F; Vendruscolo M; Dobson CM
Nat Commun; 2019 Jan; 10(1):225. PubMed ID: 30644384
[TBL] [Abstract][Full Text] [Related]
7. Protein mimetic 2D FAST rescues alpha synuclein aggregation mediated early and post disease Parkinson's phenotypes.
Stillman NH; Joseph JA; Ahmed J; Baysah CZ; Dohoney RA; Ball TD; Thomas AG; Fitch TC; Donnelly CM; Kumar S
Nat Commun; 2024 Apr; 15(1):3658. PubMed ID: 38688913
[TBL] [Abstract][Full Text] [Related]
8. Olive oil tyrosols reduce α-synuclein aggregation
Hernández-García S; García-Cano B; Martínez-Rodríguez P; Henarejos-Escudero P; Gandía-Herrero F
Food Funct; 2024 Jul; 15(13):7214-7223. PubMed ID: 38817211
[TBL] [Abstract][Full Text] [Related]
9. Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.
Limbocker R; Mannini B; Ruggeri FS; Cascella R; Xu CK; Perni M; Chia S; Chen SW; Habchi J; Bigi A; Kreiser RP; Wright AK; Albright JA; Kartanas T; Kumita JR; Cremades N; Zasloff M; Cecchi C; Knowles TPJ; Chiti F; Vendruscolo M; Dobson CM
Commun Biol; 2020 Aug; 3(1):435. PubMed ID: 32792544
[TBL] [Abstract][Full Text] [Related]
10. Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
Palazzi L; Fongaro B; Leri M; Acquasaliente L; Stefani M; Bucciantini M; Polverino de Laureto P
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199427
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembled Cyclic d,l-α-Peptides as Generic Conformational Inhibitors of the α-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies.
Chemerovski-Glikman M; Rozentur-Shkop E; Richman M; Grupi A; Getler A; Cohen HY; Shaked H; Wallin C; Wärmländer SK; Haas E; Gräslund A; Chill JH; Rahimipour S
Chemistry; 2016 Sep; 22(40):14236-46. PubMed ID: 27539220
[TBL] [Abstract][Full Text] [Related]
12. [Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling].
Galvagnion C; Buell AK
Med Sci (Paris); 2015; 31(6-7):597-600. PubMed ID: 26152159
[No Abstract] [Full Text] [Related]
13. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical Effect of Trehalose on the Aggregation of α-Synuclein: Expedites Onset of Aggregation yet Reduces Fibril Load.
Katyal N; Agarwal M; Sen R; Kumar V; Deep S
ACS Chem Neurosci; 2018 Jun; 9(6):1477-1491. PubMed ID: 29601727
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of Cu
Lorentzon E; Kumar R; Horvath I; Wittung-Stafshede P
Biometals; 2020 Jun; 33(2-3):97-106. PubMed ID: 32170541
[TBL] [Abstract][Full Text] [Related]
16. A SUMO1-Derived Peptide Targeting SUMO-Interacting Motif Inhibits α-Synuclein Aggregation.
Liang Z; Chan HYE; Lee MM; Chan MK
Cell Chem Biol; 2021 Feb; 28(2):180-190.e6. PubMed ID: 33444530
[TBL] [Abstract][Full Text] [Related]
17. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
Teng Y; Zhao J; Ding L; Ding Y; Zhou P
Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
[TBL] [Abstract][Full Text] [Related]
18. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
Zaidi FK; Deep S
Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603
[TBL] [Abstract][Full Text] [Related]
19. Role of Sporadic Parkinson Disease Associated Mutations A18T and A29S in Enhanced α-Synuclein Fibrillation and Cytotoxicity.
Kumar S; Jangir DK; Kumar R; Kumari M; Bhavesh NS; Maiti TK
ACS Chem Neurosci; 2018 Feb; 9(2):230-240. PubMed ID: 28841377
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.
Levine PM; Galesic A; Balana AT; Mahul-Mellier AL; Navarro MX; De Leon CA; Lashuel HA; Pratt MR
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1511-1519. PubMed ID: 30651314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
